Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2001

View Archived Issues

Bakuchiol has in vitro antimicrobial activity against oral pathogens

Past exposure to vaccines may reduce risk of Alzheimer's disease

Transition Therapeutics acquires intellectual property to methyldonor technology for MS

Garlic supplements shown to interfere with HIV medication

Endovasc's NRA moves towards clinical development

Genaissance and AstraZeneca sign genomics agreement

Atugen and Oxford GlycoSciences collaborate on target validation

Genzyme and Pharming reach agreement

Discovery and Quintiles form Surfaxin sales and marketing alliance

Pexelizumab collaboration reviewed; 5G1.1 progress updated

Enrollment ahead of schedule in ISAtx-247 phase II psoriasis trial

Adolor receives three SBIR grants for pain relief research

Genaera identifies and targets novel gene in asthma

Antiangiogenic agent SU-6668/TSU-68 particularly effective against breast cancer

Mechanism of SAANDs confirmed in breast cancer cells

New therapeutic option available to leukemia patients in the U.K.

CDRI-93/478: preclinical compound for hypertension and myocardial ischemia

FR-226807, a highly potent and selective PDE5 inhibitor, compares favorably with sildenafil

TRAIL active against primary CLL and WSU-CLL alone and in combination with chemotherapeutic agents

New malaria vaccine offers significant protection against Plasmodium falciparum

First small-molecule cancer targets selected from BMS-Exelixis collaboration

Potent DP receptor antagonists claimed by Merck Frosst for allergic conditions

Roche spin-off company patents new triazole antifungal agents

Aminophenoxyacetamides with neuroprotective properties synthesized at Suntory

Inhibitors of NHE-3 designed by Merck KGaA

Preparation and use of nonpeptide MetAP2 inhibitors reported by GSK

Potent and selective inhibitors of thrombin disclosed by Corvas in recent patent

Distinctive endocrine profile of abarelix compared with LHRH agonists in prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...